Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-10 · accession 0001209191-22-009252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-14 | 2022-02-10 | VRTX | WAGNER CHARLES F JR | EVP, CFO | F - Tax | $237.74 | -2,434 | 55.0K | -4% | -$578.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-10 | F | D | 2,434 | $237.74 | 55,001 | D | — | — |